INS and Alzheimer disease: It is well known that Aβ peptides are metabolized by the insulin-degrading enzyme (IDE) that also metabolize insulin [10] and that hyperinsulinemia due to peripheral insulin resistance and conditions associated with impaired glucose metabolism, such as obesity, or type 2 diabetes, are linked to cognitive dysfunction and AD [26].